Skip to content

Clinical trials

Completed Hepatitis B, Chronic trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Status: Completed Country / region: Hong Kong Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20053
20062
20073
20082
20092
20112
20122
20131
20152
20164
20175
20184
20191
20206
20214
20224
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche11
GlaxoSmithKline7
Gilead Sciences6
The University of Hong Kong5
Vir Biotechnology, Inc.5
Assembly Biosciences4
Arbutus Biopharma Corporation2
Bristol-Myers Squibb2
Aligos Therapeutics1
AusperBio Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic53
Hepatitis B19
Hepatitis8
Liver Diseases2
Bronchiolitis Obliterans Syndrome1
Chronic Disease1
DNA Virus Infections1
Fibrosis1
HIV Seropositivity1
Hepatitis, Chronic1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.